Diuretics and beta-blockers: is there a risk for dyslipidemia?

Diuretics and beta-blockers: is there a risk for dyslipidemia?

Item
http://www.wikidata.org/entity/Q33807671
A novel approach to treatment of hypertension in diabetic patients - a multicenter, double-blind, randomized study comparing the efficacy of combination therapy of Eprosartan versus Ramipril with low-dose Hydrochlorothiazide and Moxonidine on bloodEffects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart diseaseSocioeconomic position across the lifecourse & allostatic load: data from the West of Scotland Twenty-07 cohort study.The role of material, psychosocial and behavioral factors in mediating the association between socioeconomic position and allostatic load (measured by cardiovascular, metabolic and inflammatory markers).Reaction time in adolescence, cumulative allostatic load, and symptoms of anxiety and depression in adulthood: the West of Scotland Twenty-07 Study.The importance of age, sex and place in understanding socioeconomic inequalities in allostatic load: Evidence from the Scottish Health Survey (2008-2011)Metabolic side effects and cardiovascular events of diuretics: should a diuretic remain the first choice therapy in hypertension treatment? The case of yes.Patient adherence and the choice of antihypertensive drugs: focus on lercanidipine.Hypertension in kidney transplant recipients.Lipid effects of antihypertensive medications.Allostatic load as a predictor of all-cause and cause-specific mortality in the general population: Evidence from the Scottish Health Survey.Achieving goal blood pressure in patients with type 2 diabetes: conventional versus fixed-dose combination approaches.Effects of hydrochlorothiazide and propranolol treatment on chylomicron metabolism in hypertensive objects.Beta-blocker use and cardiovascular event risk in patients with heart failure with preserved ejection fraction.
P2860

Diuretics and beta-blockers: is there a risk for dyslipidemia?

Item
http://www.wikidata.org/entity/Q33807671
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@ast
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@en
type
label
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@ast
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@en
prefLabel
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@ast
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Diuretics and beta-blockers: is there a risk for dyslipidemia?
@en
P2093
P304
P31
P356
10.1016/S0002-8703(00)90325-9
P407
P433
P478
P577
P698
P921